Shizuoka, Japan

Izumi Sugo

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Izumi Sugo: Pioneering Anti-Glypican-3 Antibodies

Introduction

Izumi Sugo, located in Shizuoka, Japan, is a prominent inventor holding six patents. Her groundbreaking work in the field of antibodies, particularly the anti-glypican-3 antibody, has led to significant advancements in cancer treatment. This article explores her latest patents, career highlights, and collaborations that have shaped her innovative journey.

Latest Patents

One of Sugo's latest patents involves the anti-glypican-3 antibody which features one or more amino acid substitutions introduced in the Fc region. Notably, substitutions at the amino acid residues at positions 239, 298, 326, 330, and 332 enhance the antibody's ADCC activity. This modification proves particularly useful in treating cancers such as hepatic cancer. The patent also discloses an anticancer agent comprising this antibody alongside a pharmaceutically acceptable carrier, as well as a method for administering this agent to patients with cancer.

Career Highlights

Throughout her career, Izumi Sugo has contributed significantly to the pharmaceutical field. She has worked for notable companies, including Chugai Seiyaku Kabushiki Kaisha and Xencor, Inc. Her experiences have broadened her understanding of protein engineering and therapeutic development, allowing her to innovate effectively in her work.

Collaborations

Sugo has collaborated with esteemed colleagues such as Shigeyuki Iijima and Masamichi Sugimoto. These collaborations have enriched her research and have been instrumental in the development of her patented innovations. Working alongside skilled professionals has helped her to advance her expertise and push the boundaries of existing medical technologies.

Conclusion

Izumi Sugo's innovative spirit and dedication to her field have resulted in valuable contributions to cancer treatment through her patented anti-glypican-3 antibodies. As she continues her work, her inventions hold promise for improving patient outcomes and advancing the realm of therapeutic development. Her career serves as an inspiring example for aspiring inventors and researchers looking to make a difference through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…